Show simple item record

dc.contributor.advisorHaley Melikian
dc.contributor.authorWu, Sijia
dc.date2022-08-11T08:08:46.000
dc.date.accessioned2022-08-23T16:07:31Z
dc.date.available2022-08-23T16:07:31Z
dc.date.issued2017-01-12
dc.date.submitted2017-02-22
dc.identifier.doi10.13028/M2J01G
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32264
dc.description.abstractDopamine transporters (DAT) facilitate high-affinity presynaptic dopamine (DA) reuptake in the central nervous system, and are required to constrain extracellular DA levels and maintain presynaptic DAergic tone. DAT is the primary target for addictive and therapeutic psychostimulants, which require DAT binding to elicit reward. DAT availability at presynaptic terminals ensures its proper function, and is dynamically regulated by endocytic trafficking. My thesis research focused on two fundamental questions: 1) what are the molecular mechanisms that control DAT endocytosis? and 2) what are the mechanism(s) that govern DAT’s post-endocytic fate? Using pharmacological and genetic approaches, I discovered that a non-receptor tyrosine kinase, activated by cdc42 kinase 1 (Ack1), stabilizes DAT plasma membrane expression by negatively regulating DAT endocytosis. I found that stimulated DAT endocytosis absolutely requires Ack1 inactivation. Moreover, I was able to restore normal DAT endocytosis to a trafficking dysregulated DAT coding variant identified in an Attention Deficit Hyperactivity Disorder (ADHD) patient via constitutively activating Ack1. To address what mechanisms govern DAT’s post-endocytic fate, I took advantage of a small molecule labeling approach to directly couple fluorophore to the DAT surface population, and subsequently tracked DAT’s temporal-spatial post-endocytic itinerary in immortalized mesencephalic cells. Using this approach, I discovered that the retromer complex mediates DAT recycling and is required to maintain DAT surface levels via a DAT C-terminal PDZ-binding motif. Taken together, these findings shed considerable new light on DAT trafficking mechanisms, and pave the way for future studies examining the role of regulated DAT trafficking in neuropsychiatric disorders.
dc.language.isoen_US
dc.publisherUniversity of Massachusetts Medical School
dc.rightsLicensed under a Creative Commons license
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectDopamine Transporters
dc.subjectADHD
dc.subjectDopamine
dc.subjectProtein Kinase C
dc.subjectTyrosine Kinase
dc.subjectRetromer
dc.subjectmembrane trafficking
dc.subjectBiochemistry
dc.subjectCell Biology
dc.subjectMolecular and Cellular Neuroscience
dc.subjectMolecular Biology
dc.titleNovel Mechanisms Regulating Dopamine Transporter Endocytic Trafficking: Ack1-Controlled Endocytosis And Retromer-Mediated Recycling
dc.typeDoctoral Dissertation
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1889&context=gsbs_diss&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_diss/887
dc.legacy.embargo2017-08-22T00:00:00-07:00
dc.identifier.contextkey9732773
refterms.dateFOA2022-08-25T05:12:21Z
html.description.abstract<p>Dopamine transporters (DAT) facilitate high-affinity presynaptic dopamine (DA) reuptake in the central nervous system, and are required to constrain extracellular DA levels and maintain presynaptic DAergic tone. DAT is the primary target for addictive and therapeutic psychostimulants, which require DAT binding to elicit reward. DAT availability at presynaptic terminals ensures its proper function, and is dynamically regulated by endocytic trafficking. My thesis research focused on two fundamental questions: 1) what are the molecular mechanisms that control DAT endocytosis? and 2) what are the mechanism(s) that govern DAT’s post-endocytic fate? Using pharmacological and genetic approaches, I discovered that a non-receptor tyrosine kinase, activated by cdc42 kinase 1 (Ack1), stabilizes DAT plasma membrane expression by negatively regulating DAT endocytosis. I found that stimulated DAT endocytosis absolutely requires Ack1 inactivation. Moreover, I was able to restore normal DAT endocytosis to a trafficking dysregulated DAT coding variant identified in an Attention Deficit Hyperactivity Disorder (ADHD) patient via constitutively activating Ack1. To address what mechanisms govern DAT’s post-endocytic fate, I took advantage of a small molecule labeling approach to directly couple fluorophore to the DAT surface population, and subsequently tracked DAT’s temporal-spatial post-endocytic itinerary in immortalized mesencephalic cells. Using this approach, I discovered that the retromer complex mediates DAT recycling and is required to maintain DAT surface levels via a DAT C-terminal PDZ-binding motif. Taken together, these findings shed considerable new light on DAT trafficking mechanisms, and pave the way for future studies examining the role of regulated DAT trafficking in neuropsychiatric disorders.</p>
dc.identifier.submissionpathgsbs_diss/887
dc.contributor.departmentPsychiatry
dc.description.thesisprogramNeuroscience
dc.identifier.orcid0000-0001-5729-3973


Files in this item

Thumbnail
Name:
Wu_Sijia_preflight_version.pdf
Size:
1.636Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Licensed under a Creative Commons license
Except where otherwise noted, this item's license is described as Licensed under a Creative Commons license